Tongce Medical Investment Co., Ltd. (stock code: 600763SH) is a listed company in China whose main business is medical investment and hospital management. With medical service as the main direction, the company plans to enter a number of professional medical service fields and build a modern enterprise development strategy with medical service as the pillar.
20 12 10, Tongce Medical formed a strategic partnership with ACTA, the world's top stomatological college, to start the global selection of academic deans and establish a core clinical education and research center.
20 12, 1 10/0. In October, the Cambridge Bonn Clinic, founded by Professor robert edwards, the inventor of Tongce Medical and IVF and the winner of the Nobel Prize in 20 10, was established as a joint venture, introducing the advanced and applicable technologies and scientific management methods in the medical field of IVF, the top international assisted reproductive technology, to China.
The general medical plan should intervene in other medical service industries in a timely manner and establish a large medical service group; March into the field of maternal and child health care and promote assisted reproductive projects.
On March 8, 2020/kloc-0, Tongce Medical ranked 4th1in the Top 2020 Hurun China Health Private Enterprises1with a market value of 33 billion yuan.